Article Details

Kazia Therapeutics Announces Cantrixil Phase 1 Study Part A Results

Retrieved on: 2019-03-31 14:33:45

Tags for this article:

Click the tags to see associated articles and topics

Kazia Therapeutics Announces Cantrixil Phase 1 Study Part A Results. View article details on hiswai:

Excerpt

<div>Kazia Therapeutics Announces Cantrixil Phase 1 Study Part A Results .... to $9.5 in 2017, according to <b>Arcview Market Research</b> and BDS Analytics.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up